Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

sanofi-aventis U.S. LLC. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VIEWS: 0 PAGES: 31

Sanofi-aventis US. LLC. (Sanofi-aventis) is a pharmaceutical company. It operates through its product segments, prescription products, vaccines, other products and vermont disclosure. The company discovers, develops, and distributes therapeutic solutions. It is committed to develop safe and effective medicines, vaccines, and consumer health products. Sanofi-aventis has experience in the therapeutic areas such as, cardiovascular disease, central nervous system, internal medicine, metabolic disorders, oncology, ophthalmology, thrombosis and vaccines. The products of the company include apidra, eloxatin, lantus, jevtana and taxotere. It conducts research and development on the health care challenges in cardiology, oncology, and internal medicine, metabolic diseases, central nervous system disorders and vaccines. Sanofi-aventis is headquartered in Bridgewater, New Jersey, the US.

More Info
									                         sanofi-aventis U.S. LLC. - Pharmaceuticals & Healthcare - Deals and
                                                    Alliances Profile
       Reference Code: GDPH35590D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Sanofi-aventis US. LLC. (Sanofi-aventis) is a pharmaceutical company. It operates
                                                                                                              sanofi-aventis U.S. LLC., Pharmaceuticals &
      through its product segments, prescription products, vaccines, other products and
                                                                                                              Healthcare, Key Facts
      vermont disclosure. The company discovers, develops, and distributes therapeutic
      solutions. It is committed to develop safe and effective medicines, vaccines, and                        Web Address                        www.sanofi.us
      consumer health products. Sanofi-aventis has experience in the therapeutic areas
                                                                                                               Revenue (US$ million)                             NA
      such as, cardiovascular disease, central nervous system, internal medicine,
      metabolic disorders, oncology, ophthalmology, thrombosis and vaccines. The                               Number of Employees                                       11,400
      products of the company include apidra, eloxatin, lantus, jevtana and taxotere.                          GlobalData

      Financial Deals Landscape
        sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare, Deals                     sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare,
        by Type, 2007 to YTD 2013                                                         Deals By Year, 2007 to YTD 2013

                                                                                                          6
                                                                                                                                          5
                                                                                                          5



                                                                                           No. of Deals
                                                                                                          4
                                                                                                                          3         3
                                                                                                          3

                                                                                                          2
                                                                                                                 1                                1
                                                                                                          1
                                                                                                                                                           0         0
                                                                                                          0
                                                                                                               2007      2008    2009    2010    2011     2012    YTD
                                                                                                                                                                  2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from        from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare,                          sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013

                         14                                                                               6          5
          No. of Deals




                                                                                           No. of Deals




                         12     13                                                                        5
                         10                                                                               4
                          8
                                                                                                          3                     2         2           2
                          6
                                         3        3                                                       2                                                      1
                          4
                                                            1         1                                   1
                          2
                          0                                                                               0
                              North    Europe   South      Asia-    Middle                                      Oncolo        Central   Immun    Muscul          Ear
                              Americ             and      Pacific    East                                         gy          Nervou     ology   oskelet        Nose
                                a               Central              and                                                         s                 al          Throat
                                                Americ              Africa                                                    System                           Disorde
                                                  a                                                                                                               rs



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




sanofi-aventis U.S. LLC. - Pharmaceuticals & Healthcare - Deals                                                                                  Reference Code: GDPH35590D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                        Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................................... 3
       sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................... 5
       sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ....................................................... 6
       sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................................. 7
       sanofi-aventis U.S. LLC., Medical Devices Deals, 2007 to YTD 2013................................................................................................ 8
       sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................ 9
       sanofi-aventis U.S. LLC., Pharmaceuticals & Healthcare, Deal Details ........................................................................................... 10
          Asset Purchase............................................................................................................................................................................. 10
             Antisoma Sells Oral Fludarabine To sanofi-aventis U.S. ........................................................................................................... 10
             Antisoma Sells Oforta Rights To Sanofi-Aventis ....................................................................................................................... 12
          Partnerships.................................................................................................................................................................................. 13
             HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis ....................................................... 13
             Merck Serono Enters Into Co-Development Agreement With Sanofi-aventis............................................................................ 14
             F. Hoffmann-La Roche Forms Joint Venture With Sanofi-aventis ............................................................................................. 16
             Warner Chilcott Amends Co-Marketing Agreement With Sanofi-aventis ................................................................................... 17
             Prasco Enters Into Co-Marketing Agreement With Sanofi-aventis ............................................................................................ 18
             Biovail Enters Into Marketing And Distribution Agreement With sanofi-aventis ......................................................................... 19
             Prasco Enters Into Co-Marketing Agreement With Sanofi-aventis ............................................................................................ 20
          Licensing Agreements .................................................................................................................................................................. 21
             Sanofi-Aventis Enters Into Licensing Agreement With Barr And Teva ...................................................................................... 21
             Acton Pharma Enters Into Licensing Agreement With Sanofi-aventis For NASACORT HFA.................................................... 22
             Sanofi-aventis Enters Into Licensing Agreement With Merck Serono For AS703026 ............................................................... 23
             Merck Serono Enters Into Licensing Agreement With Sanofi-aventis For XL765...................................................................... 24
             Sanofi-Aventis Enters Into Licensing Agreement With Barr Pharma ......................................................................................... 26
       sanofi-aventis U.S. LLC. - Key Competitors ..................................................................................................................................... 28
       Key Employees ....................................................................
								
To top